Nom — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Reyedarreyedar.cominJul 2023
Reyedar develops an AI-powered eye tracking system that detects biomarkers of neurological and visual health conditions such as glaucoma and Parkinson's disease through automated oculomotor testing.
AI & Machine LearningHealthtechMedical Devices
Camiel van Vught(Founder)in
Co-investorsCottonwood Technology FundNV NOM
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


